Lv Guangfu | Pharmacology of Traditional Chinese Medicine | Best Researcher Award

Published on by Invention Awards

Mr. Lv Guangfu | Pharmacology of Traditional Chinese Medicine | Best Researcher Award 

Changchun University of Chinese Medicine | China

Mr. Lv Guangfu holds a Ph.D. in Chinese Materia Medica from Changchun University of Chinese Medicine and brings over a decade of experience in pharmaceutical R&D, specializing in drug screening and mechanistic studies of Chinese herbs for anti-tumor, neurological, and psychiatric diseases, with a particular focus on depression treatment strategies. He currently serves as Associate Vice President of R&D in a pharmaceutical company and has contributed significantly to the secondary development of a leading traditional Chinese medicine (TCM) product, establishing corporate standards and elucidating its mechanism of action, which generated RMB 20 million in profit over three years. He has also participated in preclinical research for a novel TCM drug targeting cerebral ischemia, contributing to both pharmacological and toxicological evaluations. Mr. Lv is the holder of one patent and has collaborated extensively with industry partners, producing over 30 peer-reviewed publications. His work has garnered recognition through five Jilin Provincial Science and Technology Progress Awards, reflecting both academic and practical impact. He actively engages with the professional community as a Council Member of the 2nd Board of Specialty Committee of Manchu Clinical Medicine of the World Federation of Chinese Medicine Societies and as a member of the Council of the Chinese Medicine Pharmacology Branch under the China Information Association of Chinese Medicine. His research primarily focuses on drug screening for liver cancer treatment, anti-tumor mechanisms, and depression therapeutics. His studies have attracted significant scholarly attention, earning him an h-index of 12 and more than 420 citations, demonstrating influence in Chinese medicine research and pharmacology. Through his combined industrial and academic contributions, Mr. Lv advances both innovative TCM development and evidence-based mechanistic research. His leadership in projects bridges the gap between traditional medicine and modern pharmaceutical standards, while his publications contribute to global knowledge on herbal pharmacology and drug development.

Profile: Scopus 

Featured Publications

Mechanisms of Baishao and Gancao on major depressive disorder: Network pharmacology and validation. Journal of Traditional Chinese Medicine.

 Dr. Yi -Feng  Ren | Oral Microbiology | Best Researcher Award

Published on by Invention Awards

 Dr. Yi -Feng  Ren | Oral Microbiology | Best Researcher Award

Hospital of Chengdu University of Traditional Chinese Medicine,China

Yi-Feng Ren is a dedicated medical professional specializing in oncology and clinical medicine. With a robust educational background, including a Master’s degree from Henan University and academic exchange experience at Tokyo University, he is passionate about advancing cancer research and treatment methodologies.

Profile 

Scopus 

Education 🎓

Yi-Feng Ren completed his Bachelor’s degree in Clinical Medicine at Chongqing Medical University in June 2017. He then pursued a Master’s degree in Clinical Medicine at Henan University, graduating in June 2020. He further enriched his academic experience with an exchange program at the Department of Medicine, Tokyo University, Japan, from July to September 2019. Currently, he is advancing his studies at Chengdu University of TCM in Oncology.

Experience 🏥

Ren has extensive experience in clinical and translational research, focusing on lung cancer and microbiota interactions. His contributions to the field include roles as a medical practitioner and researcher, alongside active participation in editorial boards of esteemed medical journals.

Research Interests 🔬

Role of Oral Microbiota: Investigating its impact on lung cancer prediction.

Tumor Metastasis Mechanisms: Understanding the biological processes involved in tumor spread.

Patient-Derived Organoids: Exploring clinical applications of organoids for personalized cancer treatment.

Innovative Diagnostics: Developing new approaches for cancer diagnostics.

Therapeutics Development: Advancing treatment methodologies in oncology.

Awards 🏆

Yi-Feng Ren has received various accolades for his contributions to medical research and practice, recognizing his commitment to improving patient care and advancing medical knowledge.

Selected Publications 📚

CXCL9+TAMs and TREM2+TAMs are involved in the invasion and metastasis of ground-glass and part-solid nodules in lung adenocarcinoma. Mol Cancer, 2024.

Oral microbiota as a biomarker for predicting the risk of malignancy in indeterminate pulmonary nodules: a prospective multicenter study. Int J Surg, 2025.

Mechanisms underlying the effects, and clinical applications, of oral microbiota in lung cancer: current challenges and prospects. Crit Rev Microbiol, 2023.

Patient-derived organoids of lung cancer based on organoids-on-a-chip: enhancing clinical and translational applications. Front Bioeng Biotechnol, 2023.

Saliva-microbiome-derived signatures: Expected to become a potential biomarker for pulmonary nodules (MCEPN-1). BMC Microbiol, 2024

 

Dr. Charles Reitman | Medicine and Dentistry | Best Researcher Award

Published on by Invention Awards

Dr. Charles Reitman | Medicine and Dentistry | Best Researcher Award

MUSC Health University Medical Center, United States.

Dr. Charles A. Reitman is a distinguished orthopedic surgeon specializing in spine surgery with decades of experience in medical education, research, and patient care. He has held prestigious academic positions and received numerous awards for his contributions to orthopedic and spinal surgery. Dr. Reitman is widely recognized for his expertise in minimally invasive spine techniques, spinal trauma, and disc arthroplasty.

Profile

Scopus

Orcid

🎓 Education

Charles A. Reitman, MD, pursued his undergraduate studies at the University of California, Davis, earning a BS in Animal Physiology (1974-1978). He then completed a BS and Certificate in Physical Therapy at UCSF, San Francisco (1978-1979), which provided him with foundational expertise in rehabilitation and movement sciences. Dr. Reitman later obtained his MD in Medicine from Baylor College of Medicine (1991-1995), where he developed a strong foundation in clinical practice and surgical techniques. Following medical school, he specialized in orthopedic surgery through a residency at Baylor College of Medicine (1995-2000), refining his skills in musculoskeletal care. To further specialize, he completed a fellowship in Orthopedic Surgery Spine at Baylor College of Medicine (2000-2001), gaining advanced training in complex spinal procedures.

🏥 Experience

Dr. Charles A. Reitman has had a distinguished career in orthopedic surgery, with extensive experience in both academic and clinical settings. Since 2015, he has served as a Professor of Orthopaedics at the Medical College of South Carolina, where he contributes to research, education, and advanced spinal surgery techniques. Prior to this, he was a Professor of Orthopedic Surgery at Baylor College of Medicine (2012-2015), mentoring future surgeons and leading innovative surgical advancements. His tenure at Baylor also included roles as an Associate Professor (2007-2012) and Assistant Professor (2001-2007), during which he played a pivotal role in shaping orthopedic residency programs and conducting groundbreaking research in spine surgery.

🔬 Research Interests

Spinal Surgery & Biomechanics

Minimally Invasive Spine Techniques

Disc Arthroplasty & Spinal Trauma

Spinal Deformity & Degenerative Disorders

Orthopedic Surgery Innovations

🏆 Awards & Honors

UC Davis – Highest Honors (1978)

Alpha Omega Alpha Honor Society (1995)

Baylor College of Medicine – Honors (1995)

Most Outstanding Poster – NASS (1999)

Outstanding Orthopedic Faculty, BCM (2004, 2012, 2013, 2014, 2015)

America’s Top Orthopedists (2007, 2010)

Best Doctors (2007, 2008, 2013)

Texas Super Doctors (2009)

Most Compassionate Doctor Award (2010-2016)

Top 10 Doctor (2014)

Elected into American Orthopedic Association (2011)

MUSC Ortho Faculty of the Year (2019, 2023)

Marquis Who’s Who Lifetime Award (2018)

📚 Selected Publications

Establishing case volume benchmarks for ACGME-accredited orthopedic surgery of the spine fellowship training – Spine J, 2024

Reference Data for Diagnosis of Spondylolisthesis and Disc Space Narrowing Based on NHANES-II X-rays – Bioengineering (Basel), 2024

Regional structure-function relationships of lumbar cartilage endplates – J Biomech, 2024

Diagnosis of spine pseudoarthrosis based on biomechanical properties of bone – Spine J, 2024

ACR Appropriateness Criteria® Stress (Fatigue-Insufficiency) Fracture Including Sacrum – J Am Coll Radiol, 2024

 

 

Dr. Chen Cui | Biochemistry | Best Researcher Award

Published on by Invention Awards

Dr. Chen Cui | Biochemistry | Best Researcher Award

Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, China

Cui Chen, an Assistant Researcher at the Hospital of Stomatology, Guanghua School of Stomatology, Sun Yat-Sen University, specializes in the development and regeneration of orofacial bones. With a focus on mesenchymal stem cells and their role in bone remodeling and tooth eruption, Cui has contributed extensively to the understanding of mandibular growth and alveolar bone formation. His impactful research includes high-impact publications and innovative findings in the field of stomatology.

Profile

Scopus

Orcid

Education 🎓

Dr. Chen Cui earned his Ph.D. in Stomatology from Sichuan University (2017–2020), where he conducted in-depth research on orofacial bone development and mesenchymal stem cell mechanisms in mandibular growth. Prior to this, he completed his Bachelor of Dental Surgery (BDS) at Sichuan University (2012–2017), gaining a strong foundation in dental sciences and clinical practice. His academic journey has been marked by a commitment to advancing knowledge in stomatology and regenerative dentistry.

Experience 💼

Dr. Chen  currently serves as an Assistant Researcher at the Hospital of Stomatology, Sun Yat-Sen University (2020–Present), where he focuses on groundbreaking studies in orofacial bone development and regeneration. Previously, he was a Postdoctoral Research Fellow at the same institution (2020–2022), during which he contributed significantly to projects exploring the molecular and cellular mechanisms underlying bone formation and repair. His roles demonstrate a continuous trajectory of excellence and dedication to advancing dental and craniofacial research.

Research Interests 🔬

Development and Regeneration of Orofacial Bones 🦷

Chen Cui's research delves deeply into the intricate processes of orofacial bone development and regeneration. His work aims to unravel the cellular and molecular pathways that govern the growth, repair, and restoration of craniofacial structures, addressing critical challenges in dental and craniofacial health.

Mechanisms of Mesenchymal Stem Cells in Bone and Tooth Formation 🔬

A significant focus of his studies is on mesenchymal stem cells (MSCs) and their pivotal role in the formation of bones and teeth. By exploring how MSCs contribute to tissue differentiation and regeneration, Chen Cui seeks to enhance therapeutic strategies for bone and dental restoration.

Alveolar Bone Remodeling in Inflammatory Environments 🌟

Chen Cui has investigated the impact of inflammation on alveolar bone remodeling, shedding light on how environmental factors influence bone integrity. His findings offer insights into improving treatment outcomes for conditions like periodontitis and bone loss associated with inflammatory disorders.

The Role of Parathyroid Hormone Signaling in Dental Development 🧬

Exploring the parathyroid hormone (PTH) signaling pathway, Chen Cui has identified its critical role in regulating dental development and tooth eruption. His research on PTH signaling contributes to a deeper understanding of bone health and has implications for treating dental anomalies and diseases.

Awards & Recognitions 🏆

Recipient of the National Natural Science Foundation of China Grant

Funded by the China Postdoctoral Science Foundation

Recognized by the Guangdong Basic and Applied Basic Research Foundation

Publications Top Notes 📚

PTH1R Suppressed Apoptosis of Mesenchymal Progenitors in Mandibular Growth (2024), International Journal of Molecular Sciences. Link

Klotho in Osx+ Mesenchymal Progenitors Exerts Pro-Osteogenic Effects (2022), Signal Transduction and Targeted Therapy. Cited by: 28. Link

Dental Follicle Progenitor/Stem Cells: Mechanisms to Applications (2021), Biomolecules. Cited by: 34. Link

Fibrocartilage Stem Cells in Temporomandibular Joints (2021), Frontiers in Cell and Developmental Biology Cited by: 9. Link

Role of PTH1R Signaling in Prx1+ Mesenchymal Progenitors during Eruption (2020), Journal of Dental Research Cited by: 27. Link